Abstract:Background: Primary central nervous system post-transplant lymphoproliferative disorder (PCNS-PTLD) is a rare condition, posing diagnostic and treatment challenges, with histological biopsy essential for diagnosis. Standardized treatment protocols are lacking. This disease requires urgent attention due to the increasing number of organ transplant surgeries and the use of immunosuppressive agents. Methods: From 2020 to 2023, our center diagnosed five patients with PCNS-PTLD. We reviewed their clinical records and conducted a comprehensive analysis of 22 literatures on PCNS-PTLD cases following renal transplantation or allogeneic hematopoietic stem cell transplantation (HSCT). Results: Four patients had previously received a kidney transplant, one had undergone allogeneic HSCT. The median time from the last transplant surgery to the diagnosis of PCNS-PTLD differs between kidney transplant (21.5 years) and allogeneic HSCT (9 months). Common symptoms included motor weakness ( n = 4), headache ( n = 2), confusion ( n = 2), and nausea ( n = 2), with ring-enhancing ( n = 5), typically solitary ( n = 3) and supratentorial ( n = 3) lesions on imaging. Diagnosis involved robot-assisted stereotactic brain biopsy ( n = 4) or craniotomy ( n = 1), all showing Epstein-Barr virus and CD20 positivity. Most cases ( n = 4) were monomorphic diffuse large B-cell lymphoma. Treatment included rituximab ( n = 3), surgical resection ( n = 2), zanubrutinib ( n = 1), whole-brain radiation ( n = 1), and methotrexate ( n = 1). At the last follow-up, the median duration of follow-up for all patients was 19 months. During this time, 3 patients had died and 2 patients were still alive. Conclusion: In patients with a history of kidney transplantation or allogeneic HSCT who are on long-term immunosuppressive therapy, any neurological symptoms, particularly the presence of supratentorial ring-enhancing masses in the brain on imaging, whether solitary or multiple, should raise high suspicion for this disease, warranting a timely brain biopsy. Additionally, we found that besides reducing immunosuppressants, zanubrutinib may be a potential, safe, and effective treatment for this condition. Moreover, post-surgical administration of rituximab in conjunction with whole-brain radiotherapy also appears to be a potentially safe and effective approach.

Post-transplant lymphoproliferative disorder myeloradiculopathy

Chronic Renal Disease and Reversible Posterior Leukoencephalopathy Syndrome after Liver Transplantation

A Case of Neuromyelitis Optica Spectrum Disorders Complicated with Systemic Lupus Erythematosus and Thymoma

Multicentric Castleman’s Disease in a Renal Allograft Recipient: a Case Report and Literature Review

De Novo Onset of Myasthenia Gravis after Kidney Transplantation

Cutaneous Post-transplant Lymphoproliferative Disorder

Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma

Metachronous spinal cord involvement B cell and subcutaneous tissue involvement NK/T cell lymphoid proliferations and lymphomas arising in post-transplantation mimicking general NK/T cell lymphoma: a case report and review of the literature

[A case of primary central nervous system post-transplant lymphoproliferative disease 14 years after living donor liver transplantation]

Non-Hodgkin Lymphoma with Longitudinally Extensive Transverse Myelopathy As the Initial Symptom: A Case Report.

A Case of Central Nervous System Post-Transplant Lymphoproliferative Disorder Following Haploidentical Stem Cell Transplantation in a Patient With Acute Lymphoblastic Leukemia

Spontaneous Regression of Central Nervous System Posttransplant Lymphoproliferative Disease

A disease warranting attention from neurosurgeons: primary central nervous system post-transplant lymphoproliferative disorder

Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment

Diplopia as the presenting symptom of a post‐transplant lymphoproliferative disorder in a bilateral inferior lim transplanted young adult

Liver Transplant Recipient with Tumefactive Demyelinating Lesions: A Case Report and Literature Review

Good outcome of brain stem progressive multifocal leukoencephalopathy in an immunosuppressed renal transplant patient: Importance of early detection and rapid immune reconstitution

Epstein-Barr virus-associated post-transplant smooth muscle tumours in a kidney transplant patient

Clinical and muscular pathological features with chronic graft-versus-host disease-related polymyositis: one case report

[Polymorphic lymphoproliferative disorder, lymphomatoid granulomatosis-type, in a patient with iatrogenic immunosuppression, an unusual entity]

S2564 Deciphering Deception: Pancreatic Mass Presenting as Post-Transplant Lymphoproliferative Disorder